Viatris

Provides access to medicines, advances sustainable operations, develops innovative solutions and leverages collective expertise to connect more people to more products.

Launch date

1961

Employees

10001+ people

Market cap

Enterprise valuation

AUD46.8b (Public information from Sep 2024)

Canonsburg Pennsylvania (HQ)

https://www.viatris.com/en

https://twitter.com/mylannews https://www.facebook.com/mylanfrance https://www.linkedin.com/company/viatris/

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	11.9b	17.9b	16.3b	15.4b	14.9b	14.6b	14.7b
% growth	4 %	50 %	(9 %)	(5 %)	(3 %)	(2 %)	-
EBITDA	2.1b	301m	3.4b	3.7b	4.7b	4.6b	4.7b
% EBITDA margin	18 %	2 %	21 %	24 %	32 %	32 %	32 %
Profit	(670m)	(1.3b)	2.1b	54.7m	1.5b	667m	784m
% profit margin	(6 %)	(7 %)	13 %	-	10 %	5 %	5 %
EV / revenue	4.0x	2.2x	0.8x	1.9x	1.8x	1.8x	1.6x
EV / EBITDA	22.6x	128.7x	3.9x	8.1x	5.7x	5.5x	5.1x
R&D budget	555m	751m	662m	805m	-	-	-
R&D % of revenue	5 %	4 %	4 %	5 %	-	-	-